Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT00832364
What this trial is testing

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Who this might be right for
Plaque Psoriasis
Stiefel, a GSK Company
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Testing effectiveness (Phase 2)Study completedNCT01018134
What this trial is testing

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT00195676
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,469
Large-scale testing (Phase 3)Looking for participantsNCT07362017
What this trial is testing

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Vanda Pharmaceuticals 300
Large-scale testing (Phase 3)UnknownNCT03927352
What this trial is testing

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sinocelltech Ltd. 330
Early research (Phase 1)Study completedNCT04316585
What this trial is testing

Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Who this might be right for
Psoriasis
GlaxoSmithKline 29
Large-scale testing (Phase 3)Study completedNCT02635204
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 267
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Large-scale testing (Phase 3)Study completedNCT07008547
What this trial is testing

To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
SPH-BIOCAD (HK) Limited 202
Large-scale testing (Phase 3)Study completedNCT00442650
What this trial is testing

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
Merck KGaA, Darmstadt, Germany
Large-scale testing (Phase 3)Study completedNCT07746479
What this trial is testing

Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )

Who this might be right for
Psoriasis
Livzon Pharmaceutical Group Inc. 244
Testing effectiveness (Phase 2)Study completedNCT03101670
What this trial is testing

Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 131
Large-scale testing (Phase 3)Study completedNCT04930042
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Alvotech Swiss AG 581
Large-scale testing (Phase 3)Study completedNCT02982005
What this trial is testing

KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Korea Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT02826603
What this trial is testing

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,114
Early research (Phase 1)Looking for participantsNCT05642182
What this trial is testing

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Who this might be right for
Psoriasis
SFA Therapeutics 90
Large-scale testing (Phase 3)Study completedNCT01001208
What this trial is testing

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Who this might be right for
Psoriasis
Amgen 478
Testing effectiveness (Phase 2)Looking for participantsNCT07233291
What this trial is testing

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

Who this might be right for
Psoriasis (PsO)
Ahmed Ibrahim 36
Post-approval studies (Phase 4)WithdrawnNCT04488185
What this trial is testing

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation